STA
Summit Trail Advisors Portfolio holdings
AUM
$5.83B
1-Year Return
20.79%
This Quarter Return
+6.48%
1 Year Return
+20.79%
3 Year Return
+52.92%
5 Year Return
+93.63%
10 Year Return
–
AUM
$792M
AUM Growth
–
Cap. Flow
+$792M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
2,187
New
2,182
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
$37.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$26M |
| 4 |
Apple
AAPL
|
$19.5M |
| 5 |
Shutterstock
SSTK
|
$18.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Communication Services | 15.63% |
| 2 | Technology | 14.81% |
| 3 | Energy | 11.38% |
| 4 | Financials | 8.52% |
| 5 | Healthcare | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
HSBC
HSBC
$227B
| $372K | 0.05% |
+7,332
| New | +$372K |
|
|
CLVS
277
DELISTED
Clovis Oncology, Inc.
CLVS
| $369K | 0.05% |
+5,945
| New | +$369K |
|
|
RDS.A
278
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $369K | 0.05% |
+5,168
| New | +$369K |
|
279
Royal Caribbean
RCL
$95.7B
| $360K | 0.05% |
+2,814
| New | +$360K |
|
280
Sanofi
SNY
$113B
| $356K | 0.05% |
+8,075
| New | +$356K |
|
281
Corning
GLW
$61B
| $355K | 0.04% |
+10,446
| New | +$355K |
|
282
Marsh & McLennan
MMC
$100B
| $355K | 0.04% |
+4,295
| New | +$355K |
|
283
Parker-Hannifin
PH
$96.1B
| $355K | 0.04% |
+1,721
| New | +$355K |
|
284
Raymond James Financial
RJF
$33B
| $355K | 0.04% |
+5,669
| New | +$355K |
|
285
Danaher
DHR
$143B
| $353K | 0.04% |
+4,047
| New | +$353K |
|
|
PX
286
DELISTED
Praxair Inc
PX
| $351K | 0.04% |
+2,204
| New | +$351K |
|
287
Charles Schwab
SCHW
$167B
| $349K | 0.04% |
+6,338
| New | +$349K |
|
288
Mondelez International
MDLZ
$79.9B
| $348K | 0.04% |
+7,827
| New | +$348K |
|
289
Murphy Oil
MUR
$3.56B
| $346K | 0.04% |
+9,993
| New | +$346K |
|
290
Collegium Pharmaceutical
COLL
$1.21B
| $345K | 0.04% |
+14,329
| New | +$345K |
|
|
KERX
291
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $342K | 0.04% |
+73,318
| New | +$342K |
|
292
TriMas Corp
TRS
$1.57B
| $340K | 0.04% |
+12,341
| New | +$340K |
|
293
Adobe
ADBE
$148B
| $338K | 0.04% |
+1,720
| New | +$338K |
|
294
PPL Corp
PPL
$26.6B
| $336K | 0.04% |
+10,655
| New | +$336K |
|
295
Devon Energy
DVN
$22.1B
| $334K | 0.04% |
+7,735
| New | +$334K |
|
296
Moody's
MCO
$89.5B
| $334K | 0.04% |
+2,141
| New | +$334K |
|
297
Intuit
INTU
$188B
| $332K | 0.04% |
+2,023
| New | +$332K |
|
298
Marathon Petroleum
MPC
$54.8B
| $330K | 0.04% |
+4,636
| New | +$330K |
|
299
Gibraltar Industries
ROCK
$1.82B
| $329K | 0.04% |
+8,634
| New | +$329K |
|
300
Ingevity
NGVT
$2.18B
| $328K | 0.04% |
+4,418
| New | +$328K |
|